Indefinite Delivery Contract SPE2DR25D1106

The Indefinite Delivery Contract (IDC) SPE2DR25D1106 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $9,999,999,999, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. The 11-year IDC, with a base period of 30 months and three 30-month option periods, covers an extensive array of medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This unrestricted, fully competitive acquisition aims to establish multiple Prime Vendor contracts to increase the DoD's resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract will utilize a Lowest Price Technically Acceptable evaluation criteria, with the possibility of a reverse auction to determine the final distribution fees.

The original solicitation, expected to be issued in March 2024, will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database. The Government intends to make multiple primary supplier awards for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, as well as a single award for a backup supplier covering all regions. This diversification strategy will ensure no single contractor receives an award for all the DoD's pharmaceutical requirements.